Impact of NPSR1 gene variation on the neural correlates of phasic and sustained fear in spider phobia - an imaging genetics and independent replication approach.

NPSR1 imaging genetics phasic fear sustained fear

Journal

Social cognitive and affective neuroscience
ISSN: 1749-5024
Titre abrégé: Soc Cogn Affect Neurosci
Pays: England
ID NLM: 101288795

Informations de publication

Date de publication:
21 Aug 2024
Historique:
received: 21 10 2023
revised: 13 05 2024
accepted: 19 08 2024
medline: 21 8 2024
pubmed: 21 8 2024
entrez: 21 8 2024
Statut: aheadofprint

Résumé

The functional neuropeptide S receptor 1 (NPSR1) gene A/T variant (rs324981) is associated with fear processing. We investigated the impact of NPSR1 genotype on fear processing and on symptom reduction following treatment in individuals with spider phobia. A replication approach was applied (discovery sample: Münster (MS) nMS=104; replication sample Würzburg (WZ) nWZ=81). Participants were genotyped for NPSR1 rs324981 (T-allele carriers [risk] versus AA homozygotes [no-risk]). A sustained and phasic fear paradigm was applied during functional magnetic resonance imaging. A one-session virtual reality exposure treatment (VRET) was conducted. Change of symptom severity from pre to post treatment and within session fear reduction were assessed. T-allele carriers in the discovery sample displayed lower anterior cingulate cortex (ACC) activation compared to AA homozygotes independent of condition. For sustained fear, this effect was replicated within a small cluster and medium effect size. No association with symptom reduction was found. Within-session fear reduction was negatively associated with ACC activation in T-allele carriers in the discovery sample. NPSR1 rs324981 genotype might be associated with fear processing in the ACC in spider phobia. Interpretation as potential risk-increasing function of the NPSR1 rs324981 T-allele via impaired top-down control of limbic structures remains speculative. Potential association with symptom reduction warrants further research.

Identifiants

pubmed: 39167471
pii: 7738138
doi: 10.1093/scan/nsae054
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : "Innovative Medizinische Forschung" (IMF) of the Medical Faculty, University of Münster
ID : LE121703 and LE121904
Organisme : Deutsche Forschungsgemeinschaft
ID : 44541416-TRR 58
Organisme : Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Münster
ID : Dan3/012/17

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Auteurs

Elisabeth J Leehr (EJ)

Institute for Translational Psychiatry, University of Münster, Germany.

Leonie S Brede (LS)

Institute for Translational Psychiatry, University of Münster, Germany.

Joscha Böhnlein (J)

Institute for Translational Psychiatry, University of Münster, Germany.

Kati Roesmann (K)

Institute for Clinical Psychology, University of Siegen, Germany.
Institute for Biomagnetism and Biosignalanalysis, University of Münster, Germany.
Institute for Psychology, Unit for Clinical Psychology and Psychotherapy in Childhood and Adolescence, University of Osnabrück, Germany.

Bettina Gathmann (B)

Institute of Medical Psychology and Systems Neuroscience, University of Münster, Germany.

Martin J Herrmann (MJ)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.

Markus Junghöfer (M)

Institute for Biomagnetism and Biosignalanalysis, University of Münster, Germany.
Otto-Creutzfeld Center for Cognitive and Behavioral Neuroscience, University of Münster, Germany.

Hanna Schwarzmeier (H)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.

Fabian R Seeger (FR)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.
Department of General Psychiatry, Centre for Psychosocial Medicine, University of Heidelberg, Heidelberg, Germany.

Niklas Siminski (N)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.

Thomas Straube (T)

Institute of Medical Psychology and Systems Neuroscience, University of Münster, Germany.

Anna Luisa Klahn (AL)

Department of Psychiatry and Neurochemistry and Department of Chemistry and Molecular Biology, University of Gothenburg, Sweden.

Heike Weber (H)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.

Miriam A Schiele (MA)

Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Katharina Domschke (K)

Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Ulrike Lueken (U)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.
Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
German Center for Mental Health (DZPG), partner site Berlin-Potsdam.

Udo Dannlowski (U)

Institute for Translational Psychiatry, University of Münster, Germany.

Classifications MeSH